Navigation Links
CLAAD Names Eagle Advancement Institute as Honoree of 'Top 5 Technologies To Reduce Prescription Drug Abuse'
Date:11/27/2012

WASHINGTON, Nov. 27, 2012 /PRNewswire-USNewswire/ -- The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) today announced that Eagle Advancement Institute has been named a "Top 5 Technologies To Reduce Prescription Drug Abuse" honoree for its Clarity Rapid Detox program focused on opioid addiction.

Clarity is a personalized, patented process that combines rapid detox and comprehensive aftercare delivered in person and via telehealth technology, including a customized mobile app.

"We are honored to receive this recognition from CLAAD," said James Carpenter, managing partner, Eagle Advancement Institute. "We have combined medical innovation, technology and Clarity Continuing Care to treat opioid addiction in a fast, safe, painless, confidential and effective way."

The Top 5 Technologies competition aims to increase public awareness of the U.S. prescription drug abuse epidemic, and to support private-sector efforts to address the problem.

"CLAAD is recognizing Eagle for helping to reduce prescription drug abuse through a unique combination of personal treatment, aftercare and technology," said Michael Barnes, spokesman for CLAAD.

San Diego-based Millennium Laboratories co-sponsored the Top 5 Technologies contest. Millennium provides medication monitoring, drug detection and pharmacogenetic testing services.

"We are proud to recognize Eagle and its Clarity Rapid Detox program for joining Millennium and CLAAD in our efforts to advance patient care and reduce prescription drug abuse," said Howard Appel, President of Millennium Laboratories. 

About the Center for Lawful Access and Abuse Deterrence
The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) is a national coalition of health care providers, law enforcement, community organizations, and businesses working together to reduce prescription drug abuse while optimizing patient care.  CLAAD's National Prescription Drug Abuse Prevention Strategy, which has earned the endorsements of 30 non-profit organizations, identifies the adoption of new technologies as an essential component of prescription drug abuse prevention policy.  Visit claad.org, and follow @claad_coalition

About Millennium Laboratories
Millennium Laboratories is the leading research-based, clinical diagnostic company dedicated to improving the lives of people with chronic pain and/or addiction. The company provides healthcare professionals with medication monitoring, drug detection and pharmacogenetic testing services to personalize treatment plans to improve clinical outcomes and patient safety. 

About Eagle Advancement Institute
Eagle provides Clarity, a personalized patented process for a drug-free life.


'/>"/>
SOURCE CLAAD
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CLAAD Warns of Increase in Prescription Drug Overdoses
2. Alimera Sciences Names European Management Team
3. 2012 Facility of the Year Awards Program Names Mercks Vaccine Bulk Manufacturing Facility (VBF) Program of Projects as Overall Winner
4. Amedica Names Distinguished Health Care Industry Executive Jay M. Moyes To Board Of Directors
5. Lilly Names Melissa Barnes Chief Ethics and Compliance Officer and Senior Vice President; Announces Retirement of Anne Nobles
6. Beckers Hospital Review Names 100 Hospitals With Great Womens Health Programs
7. NxStage Names Todd M. Snell Senior Vice President of Quality Assurance, Regulatory & Clinical Affairs
8. H. D. Smith Names Timothy Booth Corporate VP, Home Healthcare (HHC), In First-of-its-Kind Leadership Appointment
9. Imprimis Names Two Experts To Its Science And Regulatory Board
10. Lilly Announces Retirement of Robert Armitage, Names Michael Harrington Senior Vice President and General Counsel
11. BioMotiv Names New Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2017)... BELL, Pa. , June 1, 2017 ... (PRN) and Veterinarian Recommended Solutions (VRS), and KD Pharma ... investment in Nutriceutical Holdings by KD Pharma Group. KD ... Holdings with the option to acquire the entire company. ... partner in KD. They are committed to growing the ...
(Date:5/30/2017)... Holdings, Inc. (NYSE: HRC), will present at the Goldman Sachs ... 13, 2017, in Rancho Palos Verdes, California ... officer, is scheduled to present at 3:20 p.m. Pacific Time. ... http://ir.hill-rom.com/events.cfm . A recorded replay will be available one ... 2017. About Hill-Rom ...
(Date:5/29/2017)... TEL AVIV, Israel, May 29, 2017  Cellect Biotechnology ... of innovative technology which enables the functional selection of ... financial results for the first quarter ended March 31 ... pleased with our accomplishments in the first quarter of ... the first quarter, we announced the treatment of the ...
Breaking Medicine Technology:
(Date:6/28/2017)... ... June 28, 2017 , ... ... and financial planning assistance to clients in southern Montana, is announcing a focused ... Zoo Montana. , The outreach programs offered by Zoo Montana provide students with ...
(Date:6/28/2017)... ... June 28, 2017 , ... ... financial consultations to communities in northern Virginia and DC, is announcing a cooperative ... for patients with Alzheimer’s and other disorders that lead to memory impairment. , ...
(Date:6/27/2017)... ... June 27, 2017 , ... Excel Medical, the ... to the position of Executive Vice President, Sales and Marketing. Finnegan is a ... and medical device sales leadership. He has received industry recognition for innovations and ...
(Date:6/27/2017)... ... June 27, 2017 , ... DrugDev understands that ... they can trust the sponsor to pay them correctly and on time. As the ... establish payment strategies that encourage sites to work on their studies. , At a ...
(Date:6/27/2017)... ... June 27, 2017 , ... ... many of the health care industry’s hospitals and provider groups, has announced that ... for select customers. Parasail Health is a San Francisco health-finance startup that has ...
Breaking Medicine News(10 mins):